ArticleJCI insight2025
Matrix metalloproteinases are hallmark early biomarkers and therapeutic targets in FSHD.
Usuk Jung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleJCI insight2025
Usuk Jung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.